As both lung cancer-associated mutations described in this study were able to increase cell size of small (eIF3-depleted) cells, it may be speculated whether they associate with lung cancer types comprising of large cells – in this case NSCLC, rather than SCLC. The gene discussed is EIF3A; the disease is lung cancer.